ArticleNov 6, 2025Montai Therapeutics Presents Preclinical Data on NRF2 Agonist in Ulcerative Colitis at ACAAI Annual MeetingRead More
ArticleSep 26, 2024Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM MicroserviceRead More
Press ReleaseMay 29, 2024Montai Therapeutics Appoints Renowned Chemical Innovator Larry Hamann to Company’s Board of Directors, Convenes Multidisciplinary Scientific Advisory Board to Inform Strategic MomentumRead More
ArticleDec 13, 2023Breaking Boundaries in Chemical Combinatorics Machine Learning: Unveiling the ComboPath Model at NeurIPS 2023Read More
Press ReleaseDec 13, 2022Flagship Pioneering Unveils Montai Health to Treat and Preempt Chronic Disease Afflicting Two Billion People WorldwideRead More